JPRN-UMIN000000644已完成4 期
A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administration - GLSG,2006,CHB
Gunma Liver Study Group0 个研究点目标入组 70 人开始时间: 2014年1月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. During pregnancy and the possibility of pregnancy 2. Participating in the other clinical trials
研究者
相似试验
已完成
4 期
A open-label study of Entecavir in the patients with acute hepatitis B for preventing chronicity and aggravatioAcute hepatitis BJPRN-UMIN000000643Gunma Liver Study Group20
已完成
4 期
Entecavir for the treatment of breakthrough hepatitis caused by lamivudine and adefovir dipivoxil-resistant mutants of hepatitis B viruschronic hepaittis BJPRN-C000000393Gunma Liver Study Group (GLSG)20
已完成
4 期
A multicenter open-label trial of entecavir treatment for chronic hepatitis B and cirrhosis: Effectiveness and safetyChronic hepatitis B and cirrhosisJPRN-UMIN000000594Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences65
No Longer Available
不适用
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access ProgramChronic DiseaseHepatitis BNCT00096811Bristol-Myers Squibb
已完成
不适用
Entecavir for Chronic Hepatitis BEntecavir for Chronic Hepatitis B PatientsNCT01323452Foundation for Liver Research418